0001708138-21-000044.txt : 20210806 0001708138-21-000044.hdr.sgml : 20210806 20210806160349 ACCESSION NUMBER: 0001708138-21-000044 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20210805 FILED AS OF DATE: 20210806 DATE AS OF CHANGE: 20210806 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: YANCOPOULOS GEORGE CENTRAL INDEX KEY: 0001226690 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-19034 FILM NUMBER: 211152860 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: REGENERON PHARMACEUTICALS, INC. CENTRAL INDEX KEY: 0000872589 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 133444607 STATE OF INCORPORATION: NY FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 777 OLD SAW MILL RIVER ROAD CITY: TARRYTOWN STATE: NY ZIP: 10591 BUSINESS PHONE: 9148477000 MAIL ADDRESS: STREET 1: 777 OLD SAW MILL RIVER ROAD CITY: TARRYTOWN STATE: NY ZIP: 10591 FORMER COMPANY: FORMER CONFORMED NAME: REGENERON PHARMACEUTICALS INC DATE OF NAME CHANGE: 19930328 4 1 edgardoc.xml PRIMARY DOCUMENT X0306 4 2021-08-05 0 0000872589 REGENERON PHARMACEUTICALS, INC. REGN 0001226690 YANCOPOULOS GEORGE 777 OLD SAW MILL RIVER ROAD TARRYTOWN NY 10591 1 1 0 0 President and Chief Scientific Common Stock 2021-08-05 4 S 0 50000 600.06 D 937483 D Common Stock 2021-06-24 5 G 0 211585 0.0 A 213693 I By Trust for Chldn. Common Stock 2021-06-24 5 G 0 211585 0.0 D 0 I by 2019 GRAT Common Stock 5848 I By 401(k) Plan Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c). Represents volume-weighted average price of sales of 50,000 shares of Company stock on August 5, 2021 at prices ranging from $600.00 to $600.79. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on August 5, 2021 at each separate price. As investment trustee of trusts for the benefit of the reporting person's children. /s/**George D. Yancopoulos 2021-08-06